Top Five Pharmaceutical Company Selects Xybion's Pristima Suite for Global Deployment of Pre-Clinical Data Management

    BENSALEM, PA, March 04, 2012 /24-7PressRelease/ -- Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the sole global pre-clinical software platform by a global top-5 pharmaceutical company.

To support its new global operating model this global pharmaceutical company needed to implement a true, enterprise preclinical data management solution that could support the diverse requirements of its pre-clinical studies conducted in US and Europe in a single harmonized process. After an in-depth and thorough evaluation of all the data management options on the market, Pristima was selected as the single, integrated solution capable of supporting the global needs of this major pharmaceutical company expanding Xybion's current client footprint to 10 different countries across North America, Europe and Asia.

The global pharmaceutical company based its decision to implement Pristima on this scale based on several key requirements including the ability for the system to support a global deployment backed by services and training at the local level. Additionally, the pharmaceutical company needed to integrate several processes that were otherwise disparate in the current environment, as well as in other systems that were evaluated. Some key highlights to the decision to select Pristima include:

- An exhaustive evaluation was conducted, Pristima was chosen for its comprehensive set of features and flexibility allowing for the client to manage early discovery studies as well as general toxicology studies with one single system.
- The client will integrate General Toxicology, Clinical Pathology, Pharmacy and Pathology lab areas under one single system and one single electronic protocol.
- Pristima will be accessed globally from one single datacenter with one single database serving all of users across North America and Europe.
- Reporting and statistics included in Pristima will provide submission-ready report layouts with embedded statistical results and Pristima's automatic connectivity to document management systems further accelerates report process.

The selection of Pristima enables the client to consolidate systems from multiple suppliers and multiple versions onto a single global instance serving all of its toxicologists and pathologists, demonstrating a quick and significant ROI. Learn more about Pristima Suite at http://www.xybion.com/index.php/solutions/nw-preclincial

Dr. Pradip Banerjee, CEO of Xybion stated; "We are extremely proud of this particular contract award since it affirms our strategy to a Total Preclinical Solution. Our relationship with this key client shows our global capabilities with respect to interconnected preclinical data management and validates Xybion's ability to deliver top solutions on a global scale to life science companies."

About Xybion Corporation: http://www.xybion.com

Xybion Corporation is a global leader in the development and delivery of critical enterprise solutions to highly regulated industries. Xybion offers a comprehensive portfolio of interconnected solutions for Preclinical R&D data management, quality/ governance/risk/compliance, Enterprise Asset Management and Enterprise Content/Records Management. Xybion compliments its product portfolio with its Global Development Center, providing broad range of professional services including validation, implementation, project management and custom application development.

Xybion provides enterprise solutions for mission critical business processes for highly regulated industries. Xybion supports its global, multi-industry client base with a comprehensive portfolio of interconnected solutions that include:

Quality/ governance/risk/compliance Enterprise Asset Management

Enterprise Content & Information Management Preclinical Data Management

To support Global deployments, our Professional Services include; validation, testing, migration, integration, custom application development, business intelligence, project management, training and global support. Our business partners include: EMC,OpenText, IBM and Microsoft. Our Value Proposition is to lower our client's Total Cost of Ownership (TCO) for essential business processes, mitigate risks, accelerate growth and maintain regulatory compliance.

Website: http://www.xybion.com

# # #